Noticeability of vitiligo is in the eye of the beholder

Pandya, Amit G.; Ezzedine, Khaled

doi:10.1111/bjd.21779

Cited by 2 publications

(2 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[7][8][9][10][11][12][13][14][15][16][17][18][19][20][21][22][23][24][25] Ongenae et al noted that women were more embarrassed and selfconscious about the disease, more impaired in their daily routine and more influenced in their choice of clothing than men. 9,10,30,31 In our study, the age of the studied group of patients with vitiligo had a significant statistical impact on the quality of life. The quality of life was significantly worse in the study group of 16-30 years compared to the population of 51-60 and over 60 years in terms of symptoms, daily activities and leisure activities and treatment.…”

Section: Discussionmentioning

confidence: 51%

See 1 more Smart Citation

Quality of life in patients with vitiligo in North Macedonia

Teovska-Mitrevska

2023

Arch Pub Health

View full text Add to dashboard Cite

Vitiligo is an acquired depigmentation deficit with a high prevalence, ranging from 0.5% to 7.8%. The aim of the study was to measure the quality of life (QL) of patients with vitiligo, expressed through the Dermatological Quality of Life Index (DLQI). Materials and methods: This cross-sectional study was realized in a period of 1 year. Two questionnaires were used in the study. Тhe first questionnaire contains data from the DLQI, designed for use in adults over 16 years of age, taken from the Cardiff University in the UK. The second questionnaire contains demographic and clinical characteristics of patients (age, gender, place of residence, marital status, education), activity, comorbid diseases and BMI, age at onset, site of onset of lesions, duration of disease, family history, type, activity, natural course, body mass index (BMI) and therapy. Results: Among 71 subjects included in the study, the total score of the DLQI ranged from 0 to 28 (from a maximum of 30 points), and the average was 11.70 ± 5.7. Female patients had greater QL impairment (total mean value of 8.03) than men (5.99); there was a statistically significant difference between both sexes (P = 0.019). The total score of QL in terms of symptoms related to the condition in the six domains strongly affected QL of 45.1% of patients. The QL was significantly worse in the studied group of 16-30 years (13.85 ± 5.3) compared to the population of 51-60 and over 60 years (6.75 ± 5.7, and 7.0 ± 2.3). As the age of patients advanced, the QL improved. Subjects with higher education had a higher score (14.41 ± 6.6; p=0.001). Conclusion: Female patients with vitiligo have impaired QL in comparison to male. With age, the QL in patients with vitiligo improves. Patients with a lower degree of education have a better QL

show abstract

Section: Discussionmentioning

confidence: 51%

“…In the literature, patients with psoriasis had more impaired disease-related quality of life than vitiligo and alopecia areata patients. [31][32][33] In a study performed by Ongenae et al, patients with vitiligo were compared to psoriasis patients. They found a mean DLQI score of vitiligo that was lower than the score obtained for psoriasis.…”

Section: Discussionmentioning

confidence: 99%

Quality of life in patients with vitiligo in North Macedonia

Teovska-Mitrevska

2023

Arch Pub Health

View full text Add to dashboard Cite

show abstract

Facial involvement is reflective of patients’ global perception of vitiligo extent

Merhi

Salameh

Abboud

et al. 2023

British Journal of Dermatology

View full text Add to dashboard Cite

Background The involvement of visible areas in vitiligo has been found to be correlated with increased psychiatric morbidity. Even though multiple tools were developed to assess vitiligo, no cut-off for improvement or worsening of vitiligo from the patients’ perspective has been established. Objectives To determine the minimal clinically important difference (MCID) of the Self-Assessment Vitiligo Extent Score (SA-VES) for patients with vitiligo and to evaluate, from the patient’s perspective, the importance of the change in the involvement of visible areas (face and hands) in patients’ overall perception of disease worsening/improving. Methods This is a cross-sectional study in the context of the ComPaRe e-cohort. Adult vitiligo patients were invited to participate and fill in online questionnaires. They completed the SA-VES two times, with a one year interval. In addition, they answered a 5-point Likert anchor question aimed at assessing their perception of the evolution of the extent of their vitiligo. The MCID was calculated using distribution-based and anchor-based approaches. The change of vitiliginous lesions on the face or hands was compared to the overall extent of vitiligo (patches on all body areas) using a logistic regression. Results In total, 244 vitiligo patients were included in the analyses, among which 8% (n=20) were improved. The MCID in worsened patients was equal to a 1.29% body surface area (BSA) (95% CI: [1.01, 1.43]) increase of the SA-VES. For improved participants, the MCID was equal to a decrease of the total SA-VES by 1.330% (95% CI: [0.867, 1.697]). Patients’ perception of the change in their vitiligo was increased seven folds when it affected the face as compared to the rest of the body. Conclusions The changes of the facial SA-VES were highly correlated with the global impression of extent.

show abstract

Noticeability of vitiligo is in the eye of the beholder

Abstract: Linked Article: Batchelor et al. Br J Dermatol 2022; 187:548–556.

Cited by 2 publications

References 9 publications

Quality of life in patients with vitiligo in North Macedonia

Quality of life in patients with vitiligo in North Macedonia

Facial involvement is reflective of patients’ global perception of vitiligo extent

Contact Info

Product

Resources

About